Want to see HK:1789 full AI Analyst Report?
AK Medical Holdings Ltd. (1789) Stock Price & Analysis
1789 Stock Chart & Stats
- Day’s Range
- HKD 4.50 - HKD 4.69
- 52-Week Range
- HKD 4.20 - HKD 7.15
- Previous Close
- HKD 4.49
- Volume
- N/A
- Average Volume (3M)
- 2.05M
- Market Cap
- HKD 5.05B
- Enterprise Value
- HKD 4.36B
- Total Cash (Recent Filing)
- HKD 1.19B
- Total Debt (Recent Filing)
- HKD 12.93M
- Price to Earnings (P/E)
- 11.4
- Beta
- 0.92
- Next Earnings
- Mar 31, 2027 (Est.)
- EPS Estimate
- 0.22
- Last Dividend Ex-Date
- Jun 23, 2026
- Dividend Yield
- 2.59%
Bulls Say, Bears Say
Bulls Say
Strong Profitability
High gross, operating, and net margins demonstrate strong economics in the orthopedic device business and indicate effective cost discipline. These margins provide internal funding capacity for product development and commercial investment, while creating resilience if demand or pricing becomes less favorable.
Conservative Balance Sheet
Very low leverage gives AK Medical substantial financial flexibility and reduces exposure to interest costs or refinancing pressure. Growing equity alongside assets supports the durability of its capital base and leaves more capacity to fund operations, investment, or expansion through the business cycle.
Positive Free Cash Flow
Positive operating and free cash flow show that the company is converting a meaningful portion of its business activity into cash. The year-over-year free-cash-flow increase strengthens internally generated funding for research, commercial execution, and other long-term corporate needs.
Bears Say
Cash-Flow Volatility
The sharp deterioration in 2023 shows that reported profitability does not always translate smoothly into cash generation. Such volatility can make internal funding less predictable and may complicate investment planning, even though cash flow recovered to positive levels by 2025.
Uneven Revenue Growth
Revenue growth has not been consistently strong, with weakness in 2024 and only modest reported growth in 2025. Uneven top-line expansion can limit operating leverage and make it harder to sustain the company’s current profitability while building a steadily larger earnings base.
Returns Below Peak
Although returns improved, profitability on the capital base remains below the company’s earlier peak. The normalization from 2020 margins and ROE suggests that current earnings efficiency is not at its historical best, which may constrain the pace of value creation from future growth.
AK Medical Holdings Ltd. News
1789 FAQ
What was AK Medical Holdings Ltd.’s price range in the past 12 months?
What is AK Medical Holdings Ltd.’s market cap?
When is AK Medical Holdings Ltd.’s upcoming earnings report date?
How were AK Medical Holdings Ltd.’s earnings last quarter?
Is AK Medical Holdings Ltd. overvalued?
Does AK Medical Holdings Ltd. pay dividends?
What is AK Medical Holdings Ltd.’s EPS estimate?
How many shares outstanding does AK Medical Holdings Ltd. have?
What happened to AK Medical Holdings Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of AK Medical Holdings Ltd.?
What is the TipRanks Smart Score and how is it calculated?
AK Medical Holdings Ltd. Stock Smart Score
Company Description
AK Medical Holdings Ltd.
AK Medical Holdings Limited, an investment holding enterprise, specializes in the research, development, production, and worldwide commercialization of orthopedic joint implants and related medical devices under the AK Medical brand. Its comprehensive product offerings encompass conventional knee, hip, and spine replacement implants, as well as advanced 3D-printed solutions like hip implants, artificial vertebral bodies, and spinal interbody cages. The company further expands its operations by distributing orthopedic products from third-party manufacturers and by fabricating surgical instruments and medical irrigators. Its diverse client base spans distributors, hospitals, physicians, surgeons, and directly serves patients. Established in Beijing, People's Republic of China, in 2003, AK Medical Holdings Limited functions as a subsidiary of Ximalaya Limited.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Zhijiang Li
- Employees
- 1,004
- Website
- www.ak-medical.net
- Address
- AK Medical Industrial Park, Beijing, BE, 102299, CN
AK Medical Holdings Ltd. (1789) Earnings & Revenues
1789 Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 7 | 6 | 9 |
| Technical Analysis | 2 | 6 | 2 |
| Moving Averages | 5 | 0 | 7 |







